CAJ | 학술논문

血栓形成是机体正常的一种保护机制,可以分为生理性凝血和病理性凝血.随着人口老龄化加重、环境恶化、血栓栓塞疾病发病率的升高,人们对于血栓疾病的重视程度逐渐增加.深入归纳并研究抗凝药物,对预防血栓栓塞症的发生有重大的意义.本文总结抗凝药物的研究现况及进展,以期指导临床工作并为以后研发新的抗凝药物研究提供依据.
혈전형성시궤체정상적일충보호궤제,가이분위생이성응혈화병이성응혈.수착인구노령화가중、배경악화、혈전전새질병발병솔적승고,인문대우혈전질병적중시정도축점증가.심입귀납병연구항응약물,대예방혈전전새증적발생유중대적의의.본문총결항응약물적연구현황급진전,이기지도림상공작병위이후연발신적항응약물연구제공의거.
Thrombosis is a normal protective mechanism of the body and can be divided into physiological and pathological clotting.With aging population, environmental pollution and the rising incidence of thromboembolism, we should pay attention to the thrombophilia.It is significant in the prevention of thromboembolism, if we induct and study the anticoagulants.This paper summarizes the research progress of the anticoagulants in order to guide clinical work and provide a basis for future research.